Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised


Janssen H., van Zonneveld M., Senturk H., Zeuzem S., Akarca U., Cakaloglu Y., ...Daha Fazla

LANCET, cilt.365, ss.123-129, 2005 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 365 Konu: 9454
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1016/s0140-6736(05)17701-0
  • Dergi Adı: LANCET
  • Sayfa Sayıları: ss.123-129

Özet

Background Treatment of HBeAg-positive patients with chronic hepatitis B is not effective in most. A combination of immunomodulatory pegylated interferon alfa-2b and antiviral lamivudine might improve the rate of sustained response.